• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. A Randomized, Multicenter, Open-Label, Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhi

A Randomized, Multicenter, Open-Label, Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhi

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户：a471839794
【摘 要】
：
Background CLL is one of the most common forms of leukemia among adults.Despite advances in the treatment of CLL,including chemotherapy,chemoimmunotherapy (CIT),and stem cell transplant (SCT),the dise
【作 者】
：
Shenmiao Yang Jianyong Li Lugui Qiu Daobin Zhou Junmin Li Xiaoyan Ke Yu Hu Peng Wu Na Li Angela Howes Jingzhao Wang Steven Sun 
【机 构】
：
Peking University Peoples Hospital,Beijing,China
【出 处】
：
The 35th World Congress of the International Society of Hema
【发表日期】
：
2014年5期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background CLL is one of the most common forms of leukemia among adults.Despite advances in the treatment of CLL,including chemotherapy,chemoimmunotherapy (CIT),and stem cell transplant (SCT),the disease remains essentially incurable.
其他文献
Multicenters Egyptian Experience Of Autologous Stem Cell Transplantation In Non Hodgkin Lymphoma Com
Background The Non-Hodgkin lymphomas (NHL) comprise a heterogeneous group of malignancies.NHL includes both B-cell and T-cell malignancies.High dose chemotherapy followed by autologous stem cell trans
会议
Mobilising peripheral hematopoietic stem cell using biosimilar granulocyte colony stimulating factor
Introduction Mobilisation of hematopoietic peripheral blood stem cell (PBSC) represent a standard procedure in patients prior to an autologous stem cell transplant.Starting 2008,the biosimilars GCSF w
会议
Oral versus Intravenous Fludarabine as part of a reduced-Intensity conditioning for allogeneic stem
Introduction Oral fludarabine was introduced in the United States in 2003 for the treatment of patients with hematologic malignancies as an alternative to its intravenous(i.v.) formulation,introduced
会议
Macroeconomic Aspects Of Hematopoietic Stem Cell Transplantation And Potential Implications
Background Transplantation of cells,tissues,and organs has been recognized by the World Health Organization (WHO) as an important medical task for its member states.
会议
A novel therapy of haploidentical transplantation combined with umbilical cord blood unit provides s
HLA-mismatched/haploidentical transplantation for high-risk hematologic malignancies is associated with the increased risk of severe aGVHD,and poor overall survival (OS).We conducted a haploidentical
会议
The intensive myeloablative chemotherapy conditioning regimen without ATG for hematologic malignanci
Objective As the engraftment failure and opportunistic infections are still the main obstacles of unrelated cord blood transplantation (UCBT),the selection of conditioning regimen become a key factor
会议
Comparable 2-y OS and PFS among uCBT, rPBSCT and uBMT in adult patients with standard-risk hematolog
Background The number of uCBT is increasing to the level of 1200 cases per year,which is comparable to those of uBMT and rPBSCT in Japan.However there is few data on the comparative outcomes of adult
会议
Laparoscopic splenectomy (LS) for chronic immune thrombocytopenia: case analysis
Objective To investigate the safety and effectiveness of laparoscopic splenectomy (LS) for immune thrombocytopenia patients with platelet count lower than 10×109/L and the long-term prognosis of LS fo
会议
Molecular monitoring using peripheral blood combined with bone marrow at 3 months or 6 months provid
Backgroud Both peripheral blood (PB) and bone marrow (BM) can be used for molecular monitoring by quantitative real-time RT-PCR (Q-PCR) for chronic myeloid leukemia(CML).Aim To determine whether molec
会议
Low-dose decitabine promotes megakaryocyte maturation and platelet production in primary immune thro
Objective Impaired megakaryocyte maturation and insufficient platelet production participate in the pathogenesis of primary immune thrombocytopenia (ITP).The demethylating agent,decitabine (DAC) has b
会议